Clinical Spotlight Series: SGLT2is: The New Pillar in Heart Failure Care

false

Catalog

SGLT2is: The New Pillar in Heart Failure Care

What You Will Learn

Identify clinical indications and key considerations for selection of SGLT2 inhibitors

Establish a contemporary prescribing timeline for SGLT2 inhibitors

Practical considerations of SGLT2is including initiation, dosing, and monitoring

Overcome barriers to SGLT2i initiation

Meeting On Demand

An educational activity that has been recorded for viewing

SGLT2is: The New Pillar in Heart Failure Care

Certified Patient Cases

Apply your knowledge to patient case scenarios.

Improving Symptoms and Outcomes in a 68-year-old woman with Symptomatic Systolic HF

Optimizing HF Care in a 62-year-old man with Systolic HF and Hospital Admission

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:

Alison L. Bailey, MD, FACC

James L. Januzzi, Jr., MD, FACC

Nosheen Reza, MD, FACC

Shashank S. Sinha, MD, FACC

Muthiah Vaduganathan, MD, FACC

Supported by an independent educational grant from: AstraZeneca and Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company | Page Launched: April 2022